Literature DB >> 11094046

Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation.

P Schauerte1, B J Scherlag, J Pitha, M A Scherlag, D Reynolds, R Lazzara, W M Jackman.   

Abstract

BACKGROUND: Vagal stimulation shortens the atrial effective refractory period (AERP) and maintains atrial fibrillation (AF). This study investigated whether the parasympathetic pathways that innervate the atria can be identified and ablated by use of transvenous catheter stimulation and radiofrequency current catheter ablation (RFCA) techniques. METHODS AND
RESULTS: In 11 dogs, AERPs were determined at 7 atrial sites during bilateral cervical vagal nerve stimulation (VNS) and electrical stimulation of the third fat pad (20 Hz) in the right pulmonary artery (RPA). VNS shortened the AERP at all sites (from 123+/-4 to 39+/-4 ms, P<0.001) and increased the covariance of AERP (COV-AERP) (from 9+/-3% to 27+/-13%, P<0.001). RPA stimulation shortened the AERP at all sites from 123+/-4 to 66+/-13 ms (P<0.001) and increased the COV-AERP from 9+/-3% to 30+/-12% (P<0.001). In 7 dogs, transvascular RFCA of the parasympathetic pathways along the RPA was performed, and in 3 dogs, additional RFCA of parasympathetic fibers along the inferior (n=2) or superior (n=1) vena cava was performed. RFCA blunted the AERP shortening at all sites during VNS (114+/-4 ms after RFCA), abolished the increase of COV-AERP during VNS (12+/-7% after RFCA), and led to an increase of the baseline AERP (123+/-4 ms before versus 127+/-3 ms after RFCA, P=0.002). Before RFCA, AF could be induced and maintained as long as VNS was continued, whereas after RFCA, AF was no longer inducible during VNS.
CONCLUSIONS: -Transvascular atrial parasympathetic nerve system modification by RFCA abolishes vagally mediated AF. This antifibrillatory procedure may provide a foundation for investigating the usefulness of neural ablation in chronic animal models of AF and eventually in patients with AF and high vagal tone.

Entities:  

Mesh:

Year:  2000        PMID: 11094046     DOI: 10.1161/01.cir.102.22.2774

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  75 in total

1.  Curative catheter ablation for atrial fibrillation.

Authors:  Eric D Good; Hakan Oral
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

2.  Pulmonary vein encircling ablation alters the atrial electrophysiologic response to autonomic stimulation.

Authors:  Peter Salem Spector; Arshia Mehdi Noori; Nicholas Jackson Hardin; James Daniel Calame; Steve Paul Bell; Daniel Lawrence Lustgarten
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

3.  [Guidelines for catheter ablation].

Authors:  Karl-Heinz Kuck; Sabine Ernst; Uwe Dorwarth; Ellen Hoffmann; Heinz Pitschner; Jürgen Tebbenjohanns; Hans Kottkamp
Journal:  Clin Res Cardiol       Date:  2007-11       Impact factor: 5.460

Review 4.  [New developments for surgical ablation of atrial fibrillation].

Authors:  W Hemmer; J O Böhm
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-06

5.  Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA.

Authors:  Xiongtao Liu; Jian Yang; Fujun Shang; Changming Hong; Wangang Guo; Bing Wang; Qiangsun Zheng
Journal:  Mol Biol Rep       Date:  2008-07-18       Impact factor: 2.316

6.  Visualizing ablation gaps in vitro using a deflectable fiber optic endocardial visualization catheter.

Authors:  Afraaz R Irani; Bryant Lin; Christian Eversull; Henry H Hsia; Paul C Zei; Paul J Wang; Amin Al-Ahmad
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

7.  Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: interplay between rotors and focal discharges.

Authors:  Masatoshi Yamazaki; Luis M Vaquero; Luqia Hou; Katherine Campbell; Sharon Zlochiver; Matthew Klos; Sergey Mironov; Omer Berenfeld; Haruo Honjo; Itsuo Kodama; José Jalife; Jérôme Kalifa
Journal:  Heart Rhythm       Date:  2009-05-14       Impact factor: 6.343

8.  Is there a link between gastroesophageal reflux disease and atrial fibrillation?

Authors:  Jeffrey S Kunz; Brian Hemann; J Edwin Atwood; Jeffrey Jackson; Timothy Wu; Carolyn Hamm
Journal:  Clin Cardiol       Date:  2009-10       Impact factor: 2.882

Review 9.  Evidence-based approach to ablating atrial fibrillation.

Authors:  Takumi Yamada; G Neal Kay
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

Review 10.  More types than one: multiple muscarinic receptor coupled K+ currents undergo remodelling in an experimental model of atrial fibrillation.

Authors:  A F James; J C Hancox
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.